{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T22:10:07Z","timestamp":1794780607516,"version":"4.9.1"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T00:00:00Z","timestamp":1681948800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010574","name":"China Academy of Space Technology","doi-asserted-by":"publisher","award":["2022QNRC001"],"award-info":[{"award-number":["2022QNRC001"]}],"id":[{"id":"10.13039\/501100010574","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007219","name":"Shanghai Municipal Natural Science Foundation","doi-asserted-by":"publisher","award":["23ZR1477600"],"award-info":[{"award-number":["23ZR1477600"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82003711"],"award-info":[{"award-number":["82003711"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.biopha.2023.114750","type":"journal-article","created":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T20:58:44Z","timestamp":1682110724000},"page":"114750","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Iron deficiency in hepatocellular carcinoma cells induced sorafenib resistance by upregulating HIF-1\u03b1 to inhibit apoptosis"],"prefix":"10.1016","volume":"163","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8724-8396","authenticated-orcid":false,"given":"Zelong","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongyao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changquan","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diya","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ce","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7576-8928","authenticated-orcid":false,"given":"Yuxiao","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biopha.2023.114750_bib1","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"11","key":"10.1016\/j.biopha.2023.114750_bib2","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1080\/17474124.2021.1991792","article-title":"Current epidemiology in hepatocellular carcinoma","volume":"15","author":"Konyn","year":"2021","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"issue":"23","key":"10.1016\/j.biopha.2023.114750_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222313071","article-title":"Evaluating the effect of lenvatinib on sorafenib-resistant hepatocellular carcinoma cells","volume":"22","author":"Shi","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2023.114750_bib4","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41392-020-0187-x","article-title":"The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects","volume":"5","author":"Tang","year":"2020","journal-title":"Signal Transduct. Target Ther."},{"issue":"5","key":"10.1016\/j.biopha.2023.114750_bib5","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nrc3495","article-title":"Iron and cancer: more ore to be mined","volume":"13","author":"Torti","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2023.114750_bib6","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/8865791","article-title":"Crosstalk between macrophages, T cells, and iron metabolism in tumor microenvironment","volume":"2021","author":"Shen","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"6","key":"10.1016\/j.biopha.2023.114750_bib7","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1002\/hep.20241","article-title":"Oxidative damage is increased in human liver tissue adjacent to hepatocellular carcinoma","volume":"39","author":"Jungst","year":"2004","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.biopha.2023.114750_bib8","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1053\/jhep.2002.33204","article-title":"Proteomic analysis and molecular characterization of tissue ferritin light chain in hepatocellular carcinoma","volume":"35","author":"Park","year":"2002","journal-title":"Hepatology"},{"issue":"130","key":"10.1016\/j.biopha.2023.114750_bib9","first-page":"426","article-title":"Immunohistochemical demonstration of transferrin receptor 1 and 2 in human hepatocellular carcinoma tissue","volume":"61","author":"Sakurai","year":"2014","journal-title":"Hepatogastroenterology"},{"issue":"2","key":"10.1016\/j.biopha.2023.114750_bib10","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.ymthe.2021.09.012","article-title":"Sphingosine-1-phosphate transporter spinster homolog 2 is essential for iron-regulated metastasis of hepatocellular carcinoma","volume":"30","author":"Li","year":"2022","journal-title":"Mol. Ther."},{"issue":"3","key":"10.1016\/j.biopha.2023.114750_bib11","first-page":"272","article-title":"Iron, inflammation and invasion of cancer cells","volume":"88","author":"Fischer-Fodor","year":"2015","journal-title":"Clujul Med"},{"key":"10.1016\/j.biopha.2023.114750_bib12","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cbi.2013.12.011","article-title":"Antiproliferative activity and therapeutic implications of potassium tris(4-methyl-1-pyrazolyl) borohydride in hepatocellular carcinoma","volume":"213","author":"Jin","year":"2014","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.biopha.2023.114750_bib13","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1016\/j.crfs.2022.11.001","article-title":"An iron-deficient diet prevents alcohol- or diethylnitrosamine-induced acute hepatotoxicity in mice by inhibiting ferroptosis","volume":"5","author":"Gao","year":"2022","journal-title":"Curr. Res. Food Sci."},{"key":"10.1016\/j.biopha.2023.114750_bib14","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.semcancer.2019.10.013","article-title":"The role of cell signaling in the crosstalk between autophagy and apoptosis in the regulation of tumor cell survival in response to sorafenib and neratinib","volume":"66","author":"Booth","year":"2020","journal-title":"Semin. Cancer Biol."},{"issue":"3","key":"10.1016\/j.biopha.2023.114750_bib15","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/ijc.26374","article-title":"Inhibition of autophagy potentiates the antitumor effect of the multikinase inhibitor sorafenib in hepatocellular carcinoma","volume":"131","author":"Shimizu","year":"2012","journal-title":"Int. J. Cancer"},{"issue":"12","key":"10.1016\/j.biopha.2023.114750_bib16","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202114351","article-title":"YAP\/TAZ and ATF4 drive resistance to Sorafenib in hepatocellular carcinoma by preventing ferroptosis","volume":"13","author":"Gao","year":"2021","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.biopha.2023.114750_bib17","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.canlet.2020.02.015","article-title":"Ferroptosis, a novel pharmacological mechanism of anti-cancer drugs","volume":"483","author":"Su","year":"2020","journal-title":"Cancer Lett."},{"issue":"12","key":"10.1016\/j.biopha.2023.114750_bib18","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1007\/s00432-018-2740-3","article-title":"Role of ferroptosis in hepatocellular carcinoma","volume":"144","author":"Nie","year":"2018","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.biopha.2023.114750_bib19","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/hep.28574","article-title":"Metallothionein-1G facilitates sorafenib resistance through inhibition of ferroptosis","volume":"64","author":"Sun","year":"2016","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.biopha.2023.114750_bib20","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1089\/dna.2013.2184","article-title":"Sorafenib blocks the HIF-1alpha\/VEGFA pathway, inhibits tumor invasion, and induces apoptosis in hepatoma cells","volume":"33","author":"Xu","year":"2014","journal-title":"DNA Cell Biol."},{"issue":"5","key":"10.1016\/j.biopha.2023.114750_bib21","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1002\/hep.26224","article-title":"Hypoxia-mediated sorafenib resistance can be overcome by EF24 through Von Hippel-Lindau tumor suppressor-dependent HIF-1alpha inhibition in hepatocellular carcinoma","volume":"57","author":"Liang","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2023.114750_bib22","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.freeradbiomed.2020.10.013","article-title":"Mild iron overload induces TRIP12-mediated degradation of YY1 to trigger hepatic inflammation","volume":"161","author":"Tang","year":"2020","journal-title":"Free Radic. Biol. Med."},{"issue":"11","key":"10.1016\/j.biopha.2023.114750_bib23","doi-asserted-by":"crossref","first-page":"7544","DOI":"10.1002\/jcp.30391","article-title":"Rapid responses of adipocytes to iron overload increase serum TG level by decreasing adiponectin","volume":"236","author":"Tang","year":"2021","journal-title":"J. Cell. Physiol."},{"issue":"4","key":"10.1016\/j.biopha.2023.114750_bib24","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1084\/jem.20180900","article-title":"Disruption of FBXL5-mediated cellular iron homeostasis promotes liver carcinogenesis","volume":"216","author":"Muto","year":"2019","journal-title":"J. Exp. Med."},{"issue":"10","key":"10.1016\/j.biopha.2023.114750_bib25","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1002\/hep4.2031","article-title":"Loss of SLC46A1 decreases tumor iron content in hepatocellular carcinoma","volume":"6","author":"Wang","year":"2022","journal-title":"Hepatol. Commun."},{"issue":"7831","key":"10.1016\/j.biopha.2023.114750_bib26","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/s41586-020-2668-z","article-title":"Structure of hepcidin-bound ferroportin reveals iron homeostatic mechanisms","volume":"586","author":"Billesb\u00f8lle","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2023.114750_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2019.102610","article-title":"The microenvironmental and metabolic aspects of sorafenib resistance in hepatocellular carcinoma","volume":"51","author":"Xia","year":"2020","journal-title":"EBioMedicine"},{"issue":"4","key":"10.1016\/j.biopha.2023.114750_bib28","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1002\/hep.30923","article-title":"CRAF methylation by PRMT6 regulates aerobic glycolysis-driven hepatocarcinogenesis via ERK-Dependent PKM2 nuclear relocalization and activation","volume":"71","author":"Wong","year":"2020","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.biopha.2023.114750_bib29","first-page":"725","article-title":"Glycolysis module activated by hypoxia-inducible factor 1alpha is related to the aggressive phenotype of hepatocellular carcinoma","volume":"33","author":"Hamaguchi","year":"2008","journal-title":"Int J Oncol"},{"issue":"1","key":"10.1016\/j.biopha.2023.114750_bib30","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s13046-019-1194-z","article-title":"PKM2 is the target of proanthocyanidin B2 during the inhibition of hepatocellular carcinoma","volume":"38","author":"Feng","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.biopha.2023.114750_bib31","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.bbrc.2019.03.109","article-title":"PFKFB3\/HIF-1alpha feedback loop modulates sorafenib resistance in hepatocellular carcinoma cells","volume":"513","author":"Long","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.biopha.2023.114750_bib32","article-title":"Iron Deficiency Increases Phosphorylation of SP1 to Upregulate SPNS2 Expression in Hepatocellular Carcinoma","author":"Wang","year":"2022","journal-title":"Biol Trace Elem Res"},{"issue":"1","key":"10.1016\/j.biopha.2023.114750_bib33","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrc3183","article-title":"HIF1alpha and HIF2alpha: sibling rivalry in hypoxic tumour growth and progression","volume":"12","author":"Keith","year":"2011","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"10.1016\/j.biopha.2023.114750_bib34","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3164\/jcbn.15-127","article-title":"Deferasirox, an oral iron chelator, prevents hepatocarcinogenesis and adverse effects of sorafenib","volume":"58","author":"Yamamoto","year":"2016","journal-title":"J Clin Biochem Nutr"},{"key":"10.1016\/j.biopha.2023.114750_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113363","article-title":"Iron chelator deferasirox inhibits NF-kappaB activity in hepatoma cells and changes sorafenib-induced programmed cell deaths","volume":"153","author":"Jomen","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"7","key":"10.1016\/j.biopha.2023.114750_bib36","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1002\/ijc.28159","article-title":"Iron-dependent cell death of hepatocellular carcinoma cells exposed to sorafenib","volume":"133","author":"Louandre","year":"2013","journal-title":"Int. J. Cancer"},{"issue":"6","key":"10.1016\/j.biopha.2023.114750_bib37","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1080\/15384047.2016.1177677","article-title":"Iron depletion enhances the effect of sorafenib in hepatocarcinoma","volume":"17","author":"Urano","year":"2016","journal-title":"Cancer Biol. Ther."},{"issue":"5","key":"10.1016\/j.biopha.2023.114750_bib38","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41571-020-00462-0","article-title":"Broadening horizons: the role of ferroptosis in cancer","volume":"18","author":"Chen","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2023.114750_bib39","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","article-title":"Regulation of ferroptotic cancer cell death by GPX4","volume":"156","author":"Yang","year":"2014","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.biopha.2023.114750_bib40","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nchembio.2238","article-title":"Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis","volume":"13","author":"Kagan","year":"2017","journal-title":"Nat. Chem. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2023.114750_bib41","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s13046-019-1067-5","article-title":"SHMT1 inhibits the metastasis of HCC by repressing NOX1-mediated ROS production","volume":"38","author":"Dou","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"8","key":"10.1016\/j.biopha.2023.114750_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/cells10081901","article-title":"Mitochondrial metabolic signatures in hepatocellular carcinoma","volume":"10","author":"Lee","year":"2021","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.biopha.2023.114750_bib43","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1258\/ar.2012.120249","article-title":"Sorafenib suppresses the rapid progress of hepatocellular carcinoma after insufficient radiofrequency ablation therapy: an experiment in vivo","volume":"54","author":"Xu","year":"2013","journal-title":"Acta Radiol."},{"issue":"4","key":"10.1016\/j.biopha.2023.114750_bib44","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.7150\/thno.29673","article-title":"Interaction between p53 and Ras signaling controls cisplatin resistance via HDAC4- and HIF-1alpha-mediated regulation of apoptosis and autophagy","volume":"9","author":"Zhang","year":"2019","journal-title":"Theranostics"},{"issue":"11","key":"10.1016\/j.biopha.2023.114750_bib45","doi-asserted-by":"crossref","first-page":"8495","DOI":"10.1002\/jcp.29692","article-title":"Cimetidine a promising radio-protective agent through modulating Bax\/Bcl2 ratio: an in vivo study in male rats","volume":"235","author":"Estaphan","year":"2020","journal-title":"J. Cell. Physiol."},{"issue":"11","key":"10.1016\/j.biopha.2023.114750_bib46","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1097\/TP.0b013e3181bb4a07","article-title":"Repetitive hypoxic preconditioning attenuates renal ischemia\/reperfusion induced oxidative injury via upregulating HIF-1 alpha-dependent bcl-2 signaling","volume":"88","author":"Yang","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.biopha.2023.114750_bib47","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3389\/fcell.2018.00013","article-title":"Subcellular localization and dynamics of the Bcl-2 family of proteins","volume":"6","author":"Popgeorgiev","year":"2018","journal-title":"Front. Cell Dev. Biol."},{"issue":"11","key":"10.1016\/j.biopha.2023.114750_bib48","first-page":"2312","article-title":"Influences of HIF-lalpha on Bax\/Bcl-2 and VEGF expressions in rats with spinal cord injury","volume":"6","author":"Chen","year":"2013","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.biopha.2023.114750_bib49","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3389\/fphar.2020.00519","article-title":"An integrative pharmacology-based analysis of refined qingkailing injection against cerebral ischemic stroke: a novel combination of baicalin, geniposide, cholic acid, and hyodeoxycholic acid","volume":"11","author":"Ma","year":"2020","journal-title":"Front. Pharm."},{"issue":"2","key":"10.1016\/j.biopha.2023.114750_bib50","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.pathophys.2018.01.003","article-title":"Increased glomerular Bax\/Bcl2 ratio is positively correlated with glomerular sclerosis in lupus nephritis","volume":"25","author":"Hosny","year":"2018","journal-title":"Pathophysiology"},{"key":"10.1016\/j.biopha.2023.114750_bib51","doi-asserted-by":"crossref","first-page":"30717","DOI":"10.1038\/srep30717","article-title":"Novel combination of sorafenib and biochanin-A synergistically enhances the anti-proliferative and pro-apoptotic effects on hepatocellular carcinoma cells","volume":"6","author":"Youssef","year":"2016","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.biopha.2023.114750_bib52","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/sj.leu.2405098","article-title":"Sorafenib induces apoptosis of AML cells via Bim-mediated activation of the intrinsic apoptotic pathway","volume":"22","author":"Zhang","year":"2008","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.biopha.2023.114750_bib53","doi-asserted-by":"crossref","first-page":"172","DOI":"10.4149\/neo_2015_022","article-title":"Sorafenib-irinotecan sequential therapy augmented the anti-tumor efficacy of monotherapy in hepatocellular carcinoma cells HepG2","volume":"62","author":"Wang","year":"2015","journal-title":"Neoplasma"},{"issue":"8","key":"10.1016\/j.biopha.2023.114750_bib54","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1038\/sj.cdd.4401962","article-title":"The p53-Bcl-2 connection","volume":"13","author":"Hemann","year":"2006","journal-title":"Cell Death Differ."},{"issue":"2","key":"10.1016\/j.biopha.2023.114750_bib55","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jhep.2016.04.019","article-title":"ADRB2 signaling promotes HCC progression and sorafenib resistance by inhibiting autophagic degradation of HIF1alpha","volume":"65","author":"Wu","year":"2016","journal-title":"J. Hepatol."},{"issue":"14","key":"10.1016\/j.biopha.2023.114750_bib56","doi-asserted-by":"crossref","first-page":"5942","DOI":"10.1158\/0008-5472.CAN-10-0157","article-title":"The epidermal growth factor receptor antibody cetuximab induces autophagy in cancer cells by downregulating HIF-1alpha and Bcl-2 and activating the beclin 1\/hVps34 complex","volume":"70","author":"Li","year":"2010","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.biopha.2023.114750_bib57","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1007\/s00535-013-0906-y","article-title":"Combination of sorafenib and angiotensin-II receptor blocker attenuates preneoplastic lesion development in a non-diabetic rat model of steatohepatitis","volume":"49","author":"Yoshiji","year":"2014","journal-title":"J. Gastroenterol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223005395?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223005395?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T17:58:50Z","timestamp":1780336730000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223005395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":57,"alternative-id":["S0753332223005395"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.114750","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Iron deficiency in hepatocellular carcinoma cells induced sorafenib resistance by upregulating HIF-1\u03b1 to inhibit apoptosis","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.114750","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"114750"}}